IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,437 | +4.3% | 671 | -5.6% | 0.00% | 0.0% |
| Q2 2023 | $29,172 | +21.6% | 711 | +6.0% | 0.00% | 0.0% |
| Q1 2023 | $23,982 | -5.4% | 671 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $25,344 | -20.8% | 671 | -7.1% | 0.00% | 0.0% |
| Q3 2022 | $32,000 | +18.5% | 722 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $27,000 | +3.8% | 724 | +1.1% | 0.00% | 0.0% |
| Q1 2022 | $26,000 | +36.8% | 716 | +15.3% | 0.00% | 0.0% |
| Q4 2021 | $19,000 | -20.8% | 621 | -14.1% | 0.00% | 0.0% |
| Q3 2021 | $24,000 | +41.2% | 723 | +68.9% | 0.00% | 0.0% |
| Q2 2021 | $17,000 | -87.2% | 428 | -85.6% | 0.00% | -83.3% |
| Q1 2021 | $133,000 | -5.0% | 2,962 | +19.6% | 0.01% | -25.0% |
| Q4 2020 | $140,000 | +225.6% | 2,477 | +172.2% | 0.01% | +166.7% |
| Q3 2020 | $43,000 | -76.6% | 910 | -70.9% | 0.00% | -75.0% |
| Q2 2020 | $184,000 | +348.8% | 3,123 | +252.1% | 0.01% | +300.0% |
| Q1 2020 | $41,000 | -75.9% | 887 | -68.5% | 0.00% | -76.9% |
| Q4 2019 | $170,000 | +246.9% | 2,820 | +243.9% | 0.01% | +225.0% |
| Q3 2019 | $49,000 | -7.5% | 820 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $53,000 | -56.9% | 820 | -46.1% | 0.01% | -64.3% |
| Q1 2019 | $123,000 | +10.8% | 1,520 | -26.6% | 0.01% | -6.7% |
| Q4 2018 | $111,000 | -28.8% | 2,070 | -31.5% | 0.02% | -21.1% |
| Q3 2018 | $156,000 | +271.4% | 3,023 | +195.5% | 0.02% | +216.7% |
| Q2 2018 | $42,000 | -50.6% | 1,023 | -46.8% | 0.01% | -53.8% |
| Q1 2018 | $85,000 | -59.9% | 1,923 | -54.5% | 0.01% | -62.9% |
| Q4 2017 | $212,000 | +16.5% | 4,223 | +27.1% | 0.04% | +12.9% |
| Q3 2017 | $182,000 | +67.0% | 3,323 | +60.3% | 0.03% | +47.6% |
| Q2 2017 | $109,000 | -10.7% | 2,073 | -18.6% | 0.02% | +75.0% |
| Q1 2017 | $122,000 | +229.7% | 2,546 | +229.4% | 0.01% | +33.3% |
| Q4 2016 | $37,000 | – | 773 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |